LYNDA LAZAR: Open Payments
NPI 1902965122 · HARRISVILLE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 17 payments from 8 companies in 2025. Trend: 2023 $192 · 2024 $331 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $150 |
| Alkermes, Inc. | 2 | $142 |
| Neurocrine BioSciences, Inc. | 4 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| DePuy Synthes Sales Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
Products named: SPRAVATO, VIVITROL, INGREZZA, REXULTI, CAPLYTA, TRUFILL, FANAPT, ARISTADA.
Industry payments across UT — which companies pay providers there.
